Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Javier David Benítez Fuentes"'
Autor:
Kauzar Mohamed Mohamed, Kissy Guevara-Hoyer, Carlos Jiménez García, Laura García Bravo, Adolfo Jiménez-Huete, Antonia Rodríguez de la Peña, Beatriz Mediero Valeros, Cristina Cañizares Velázquez, Esther Culebras López, Noemí Cabello, Vicente Estrada, Ángel L. Corbí, Miguel Fernández-Arquero, Alberto Ocaña, Alberto Delgado-Iribarren, Mercedes Martínez-Novillo, Estefanía Bolaños, Eduardo Anguita, Ascensión Peña, Celina Benavente, Javier David Benítez Fuentes, Pedro Pérez Segura, Silvia Sánchez-Ramón
Publikováno v:
Biomedicines, Vol 11, Iss 4, p 1042 (2023)
Patients with antibody deficiency disorders, such as primary immunodeficiency (PID) or secondary immunodeficiency (SID) to B-cell lymphoproliferative disorder (B-CLPD), are two groups vulnerable to developing the severe or chronic form of coronavirus
Externí odkaz:
https://doaj.org/article/e39eb338a25e46539517e34e4325a5fe
Autor:
Santiago Cabezas-Camarero, Vanesa García-Barberán, Javier David Benítez-Fuentes, Miguel J. Sotelo, José Carlos Plaza, Alejandro Encinas-Bascones, Óscar De-la-Sen, Farzin Falahat, Jesús Gimeno-Hernández, Manuel Gómez-Serrano, Fernando Puebla-Díaz, Manuel De-Pedro-Marina, Maricruz Iglesias-Moreno, Pedro Pérez-Segura
Publikováno v:
Cancers; Volume 15; Issue 9; Pages: 2431
Neuroendocrine carcinomas (NECs) of the head and neck (HN) account for
Autor:
Kauzar Mohamed Mohamed, Kissy Guevara-Hoyer, Carlos Jiménez García, Laura García Bravo, Adolfo Jiménez Huete, Antonia Rodríguez de la Peña, Beatriz Mediero Valeros, Cristina Cañizares Velázquez, Esther Culebras López, Noemi Cabello, Vicente Estrada, Ángel López Corbi, Miguel Fernández Arquero, Alberto Ocaña, Alberto Delgado-Iribarren, Mercedes Martínez Novillo, Estefania Bolaños, Eduardo Anguita, Ascensión Peña, Celina Benavente, Javier David Benítez Fuentes, Pedro Perez Segura, Silvia Sanchez-Ramon
Patients with antibody deficiency disorders, such as common variable immunodeficiency (CVID), or secondary immunodeficiency (SIDs) to B-cell lymphoproliferative disorder (B-CLPD), are two vulnerable groups of developing severe or chronic form of coro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d40e37775ce6feb0ee19a6a2d359851e
https://doi.org/10.21203/rs.3.rs-1645228/v1
https://doi.org/10.21203/rs.3.rs-1645228/v1
Autor:
Salvador Gamez Casado, Javier David Benitez Fuentes, Beatriz Álvarez Rodríguez, Gema García Ledo
Publikováno v:
Respirology Case Reports, Vol 12, Iss 4, Pp n/a-n/a (2024)
Abstract Oncogene‐negative, PDL1‐negative metastatic non‐small cell lung cancer (NSCLC) presents significant treatment challenges due to its complexity and resistance to conventional therapies. The case report presented addresses a 55‐year‐
Externí odkaz:
https://doaj.org/article/39eeebcce12a4a34ba1b236acf2cafde
Autor:
Alicia Milagros de Luna Aguilar, Javier David Benitez Fuentes, Justo Ortega Anselmi, Jennifer Olalla Inoa, Paloma Flores Navarro, Alfonso Lopez de Sá, Jesus Fuentes Antras, Cristina Rodríguez Rey, Aída Ortega Candil, Fernando Moreno Antón, Jose Ángel García Sáenz
Publikováno v:
Cancers, Vol 15, Iss 18, p 4452 (2023)
The three approved cyclin-dependent kinase 4/6 (CDK4/6) inhibitors, including abemaciclib, have shown differences in their preclinical, pharmacological, and clinical data. Abemaciclib stands out for its broader target range and more rapid and intense
Externí odkaz:
https://doaj.org/article/209c48fdd38d4641a2d64fb6fbe5aced
Autor:
Javier David Benitez Fuentes, Kauzar Mohamed Mohamed, Alicia de Luna Aguilar, Carlos Jiménez García, Kissy Guevara-Hoyer, Miguel Fernandez-Arquero, M Antonia Rodríguez de la Peña, Laura Garciía Bravo, Alejandro Francisco Jiménez Ortega, Paloma Flores Navarro, Jorge Bartolome Arcilla, Bárbara Alonso Arenilla, Elvira Baos Muñoz, Alberto Delgado-Iribarren García-Campero, María Montealegre Sanz, Silvia Sanchez-Ramon, Pedro Perez Segura
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionEvidence is scant regarding the long-term humoral and cellular responses Q7 triggered by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccines in cancer patients after repeated booster doses. The possibility of T-cell
Externí odkaz:
https://doaj.org/article/205ced2c0cb34c1fa28fb27310f18bf2
Autor:
Ignacio Martinez Capella, Sara Gil Useros, Macarena Torrego Ellacuría, Laura Llorente Sanz, Jorge Bartolomé Arcilla, Paloma Flores Navarro, Alicia de Luna Aguilar, Alberto Delgado-Iribarren García-Campero, Javier David Benitez Fuentes, Elvira Baos Muñoz, Alejandro Francisco Jimenez Ortega, Pedro Pérez Segura
Publikováno v:
F1000Research, Vol 11 (2022)
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines efficacy and safety have been tested in phase 3 studies in which cancer patients were not included or were underrepresented. Methods: The objective of this study is to
Externí odkaz:
https://doaj.org/article/106d3de9f04449fea57a5cfd285bf249
Autor:
Alfonso Lopez de Sa Lorenzo, Paloma Flores Navarro, Berta Laguna Fonseca, Carmen Toledano Rojas, Alicia de Luna Aguilar, Javier David Benitez Fuentes, Tania Rocha Iñigo, Clara Frick, Richa Shah, Natalia Vidal Cassinello, Alejandro Francisco Jimenez Ortega
Publikováno v:
F1000Research, Vol 11 (2022)
Background: Human bocavirus (HBoV) is a viral pathogen from the genus Bocaparvovirus (family Parvoviridae, subfamily Parvovirinae) discovered in 2005. Most of available literature is about HBoV in children and adults with hematological malignancies a
Externí odkaz:
https://doaj.org/article/5519d9ff57dc4c31830f8a89d7cd6279